Neema Mayhugh, Ph.D., Director, Commercial Affairs, Cole Eye Institute. Dr. Mayhugh's current focus is on technology commercialization in the ophthalmic therapeutic area. She joins CCI from Pfizer, Inc., where she was responsible for worldwide market analytics in age-related macular degeneration. Her previous experience also includes strategic consulting in the biotech, pharmaceutical, and medical device industries and research in neurodegenerative disease at the Massachusetts General Hospital. Dr. Mayhugh received her doctorate in Pharmacology and Toxicology at Dartmouth College and her undergraduate degree in Human Physiology at Boston University.